Turco, Fabio;
Armstrong, Andrew;
Attard, Gerhardt;
Beer, Tomasz M;
Beltran, Himisha;
Bjartell, Anders;
Bossi, Alberto;
... Omlin, Aurelius; + view all
(2022)
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021.
European Urology
10.1016/j.eururo.2022.02.010.
(In press).
Preview |
Text
Turco_2022_EurUrol_APCCC.pdf - Published Version Download (445kB) | Preview |
Abstract
Patients with advanced prostate cancer (APC) may be at greater risk for severe illness, hospitalisation, or death from coronavirus disease 2019 (COVID-19) due to male gender, older age, potential immunosuppressive treatments, or comorbidities. Thus, the optimal management of APC patients during the COVID-19 pandemic is complex. In October 2021, during the Advanced Prostate Cancer Consensus Conference (APCCC) 2021, the 73 panel members voted on 13 questions on this topic that could help clinicians make treatment choices during the pandemic. There was a consensus for full COVID-19 vaccination and booster injection in APC patients. Furthermore, the voting results indicate that the expert’s treatment recommendations are influenced by the vaccination status: the COVID-19 pandemic altered management of APC patients for 70% of the panellists before the vaccination was available but only for 25% of panellists for fully vaccinated patients. Most experts (71%) were less likely to use docetaxel and abiraterone in unvaccinated patients with metastatic hormone-sensitive prostate cancer. For fully vaccinated patients with high-risk localised prostate cancer, there was a consensus (77%) to follow the usual treatment schedule, whereas in unvaccinated patients, 55% of the panel members voted for deferring radiation therapy. Finally, there was a strong consensus for the use of telemedicine for monitoring APC patients.
| Type: | Article |
|---|---|
| Title: | What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.eururo.2022.02.010 |
| Publisher version: | https://doi.org/10.1016/j.eururo.2022.02.010 |
| Language: | English |
| Additional information: | This work is licensed under an Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) |
| Keywords: | Prostate cancer; Prostate cancer management; COVID-19 pandemic; COVID-19 vaccine; COVID-19 boost injection; Telemedicine |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10143983 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
